Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bardelli

Showing results (131-140 of 281) with videos related to

Pageof 29
Sort By:
Nature Genetics|July 11, 2022
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cellsMariangela Russo, Simone Pompei, Alberto Sogari, et al.
Science (New York, N.Y.)|May 10, 2003
Mutational analysis of the tyrosine kinome in colorectal cancersAlberto Bardelli, D Williams Parsons, Natalie Silliman, et al.
Clinical and Experimental Medicine|July 29, 2025
Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancerGiulia Chisari, Emanuele Martorana, Sofia Paola Lombardo, et al.
Journal of the National Cancer Institute|October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal CancerGabriele Picco, Consalvo Petti, Francesco Sassi, et al.
Biochemical and Biophysical Research Communications|June 23, 2009
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D)Alessandro Palmioli, Elena Sacco, Cristina Airoldi, et al.
Acta Neuropathologica|February 4, 2010
The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastomaFonnet E Bleeker, Nadia A Atai, Simona Lamba, et al.
Clinical and Experimental Medicine|June 30, 2025
Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancerGiulia Chisari, Emanuele Martorana, Sofia Paola Lombardo, et al.
Cancer Research|February 19, 2009
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesAndrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathwayMargherita Pergolizzi, Laura Bizzozero, Federica Maione, et al.
Cell Reports|September 15, 2015
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer DrugsAnirudh Prahallad, Guus J J E Heynen, Giovanni Germano, et al.
Pageof 29

Showing results (131-140 of 281) with videos related to

Sort By:
Pageof 29
Nature Genetics|July 11, 2022
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cellsMariangela Russo, Simone Pompei, Alberto Sogari, et al.
Science (New York, N.Y.)|May 10, 2003
Mutational analysis of the tyrosine kinome in colorectal cancersAlberto Bardelli, D Williams Parsons, Natalie Silliman, et al.
Clinical and Experimental Medicine|July 29, 2025
Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancerGiulia Chisari, Emanuele Martorana, Sofia Paola Lombardo, et al.
Journal of the National Cancer Institute|October 25, 2016
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal CancerGabriele Picco, Consalvo Petti, Francesco Sassi, et al.
Biochemical and Biophysical Research Communications|June 23, 2009
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-Ras(G13D)Alessandro Palmioli, Elena Sacco, Cristina Airoldi, et al.
Acta Neuropathologica|February 4, 2010
The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastomaFonnet E Bleeker, Nadia A Atai, Simona Lamba, et al.
Clinical and Experimental Medicine|June 30, 2025
Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancerGiulia Chisari, Emanuele Martorana, Sofia Paola Lombardo, et al.
Cancer Research|February 19, 2009
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodiesAndrea Sartore-Bianchi, Miriam Martini, Francesca Molinari, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathwayMargherita Pergolizzi, Laura Bizzozero, Federica Maione, et al.
Cell Reports|September 15, 2015
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer DrugsAnirudh Prahallad, Guus J J E Heynen, Giovanni Germano, et al.
Pageof 29